SG176799A1 - Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt - Google Patents
Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt Download PDFInfo
- Publication number
- SG176799A1 SG176799A1 SG2011091733A SG2011091733A SG176799A1 SG 176799 A1 SG176799 A1 SG 176799A1 SG 2011091733 A SG2011091733 A SG 2011091733A SG 2011091733 A SG2011091733 A SG 2011091733A SG 176799 A1 SG176799 A1 SG 176799A1
- Authority
- SG
- Singapore
- Prior art keywords
- compound
- formula
- amide
- solvate
- conditions suitable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27007309P | 2009-07-02 | 2009-07-02 | |
| PCT/US2010/040792 WO2011002999A1 (en) | 2009-07-02 | 2010-07-01 | Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG176799A1 true SG176799A1 (en) | 2012-01-30 |
Family
ID=42937685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011091733A SG176799A1 (en) | 2009-07-02 | 2010-07-01 | Synthesis of n4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] -3-oxo-5-pyrido [1, 4] oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl) -2, 4- pyrimidinediamine disodium salt |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US8299242B2 (enExample) |
| EP (1) | EP2448950B1 (enExample) |
| JP (1) | JP5739882B2 (enExample) |
| CN (1) | CN102482305B (enExample) |
| AU (1) | AU2010266213B2 (enExample) |
| BR (1) | BRPI1011888A2 (enExample) |
| CA (1) | CA2766801C (enExample) |
| CY (1) | CY1117489T1 (enExample) |
| DK (1) | DK2448950T3 (enExample) |
| EA (1) | EA021657B1 (enExample) |
| ES (1) | ES2565985T3 (enExample) |
| HR (1) | HRP20160319T1 (enExample) |
| HU (1) | HUE027212T2 (enExample) |
| ME (1) | ME02388B (enExample) |
| PL (1) | PL2448950T3 (enExample) |
| RS (1) | RS54679B1 (enExample) |
| SG (1) | SG176799A1 (enExample) |
| SI (1) | SI2448950T1 (enExample) |
| SM (1) | SMT201600084B (enExample) |
| UA (1) | UA108077C2 (enExample) |
| WO (1) | WO2011002999A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5468899B2 (ja) | 2006-07-20 | 2014-04-09 | アフィニウム ファーマシューティカルズ， インク． | Ｆａｂｉインヒビターとしてのアクリルアミド誘導体 |
| UA108077C2 (xx) | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну | |
| US20110206661A1 (en) * | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Trimethoxyphenyl inhibitors of tyrosine kinase |
| EP2736487B2 (en) * | 2011-07-28 | 2024-08-28 | Rigel Pharmaceuticals, Inc. | New (trimethoxyphenylamino)pyrimidinyl formulations |
| TWI526437B (zh) * | 2011-09-09 | 2016-03-21 | 台灣神隆股份有限公司 | 卡巴他賽之結晶型 |
| US8426450B1 (en) * | 2011-11-29 | 2013-04-23 | Helsinn Healthcare Sa | Substituted 4-phenyl pyridines having anti-emetic effect |
| MY170437A (en) | 2012-06-19 | 2019-07-31 | Debiopharm Int Sa | Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide |
| CN102746337B (zh) * | 2012-06-21 | 2014-12-17 | 成都苑东药业有限公司 | 一种2，4-嘧啶二胺类化合物及其制备方法 |
| TW201410657A (zh) | 2012-08-02 | 2014-03-16 | Endo Pharmaceuticals Inc | 經取代胺基－嘧啶衍生物 |
| LT3083648T (lt) * | 2013-12-20 | 2019-01-25 | Rigel Pharmaceuticals, Inc. | Farmacinis būdas ir tarpiniai junginiai |
| PL3419628T3 (pl) | 2016-02-26 | 2021-05-31 | Debiopharm International Sa | Lek do leczenia zakażeń stopy cukrzycowej |
| EP3509578B1 (en) | 2016-09-08 | 2022-12-21 | Glykon Technologies Group, LLC | Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same |
| JP2020536100A (ja) * | 2017-10-04 | 2020-12-10 | セルジーン コーポレイション | シス−４−［２−｛［（３ｓ，４ｒ）−３−フルオロキサン−４−イル］アミノ｝−８−（２，４，６−トリクロロアニリノ）−９ｈ−プリン−９−イル］−１−メチルシクロヘキサン−１−カルボキサミドの製造プロセス |
| HRP20230437T1 (hr) | 2019-02-14 | 2023-07-07 | Debiopharm International S.A. | Formulacija afabicina, postupak izrade iste |
| CN113939306B (zh) | 2019-06-14 | 2024-07-19 | 德彪药业国际股份公司 | 用于治疗涉及生物膜的细菌感染的药物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US303022A (en) | 1884-08-05 | Egg-beater | ||
| US324087A (en) | 1885-08-11 | Abel combs | ||
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| US20040024716A1 (en) | 2002-04-12 | 2004-02-05 | James Malatesta | Mail sorting processes and systems |
| CN103169708B (zh) | 2002-07-29 | 2018-02-02 | 里格尔药品股份有限公司 | 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
| US7122542B2 (en) | 2003-07-30 | 2006-10-17 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| US20060047135A1 (en) | 2004-08-30 | 2006-03-02 | Chadwick Scott T | Process for preparing chloromethyl di-tert-butylphosphate |
| US7449458B2 (en) * | 2005-01-19 | 2008-11-11 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| US20090114877A1 (en) * | 2005-09-13 | 2009-05-07 | Eisai R&D Management Co., Ltd. | Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same |
| US8163902B2 (en) * | 2006-11-21 | 2012-04-24 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| UA108077C2 (xx) | 2009-07-02 | 2015-03-25 | Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну |
-
2010
- 2010-01-07 UA UAA201201072A patent/UA108077C2/ru unknown
- 2010-07-01 EP EP10730679.7A patent/EP2448950B1/en active Active
- 2010-07-01 PL PL10730679T patent/PL2448950T3/pl unknown
- 2010-07-01 HR HRP20160319TT patent/HRP20160319T1/hr unknown
- 2010-07-01 BR BRPI1011888A patent/BRPI1011888A2/pt not_active Application Discontinuation
- 2010-07-01 US US12/829,126 patent/US8299242B2/en active Active
- 2010-07-01 CN CN201080039108.1A patent/CN102482305B/zh active Active
- 2010-07-01 WO PCT/US2010/040792 patent/WO2011002999A1/en not_active Ceased
- 2010-07-01 HU HUE10730679A patent/HUE027212T2/en unknown
- 2010-07-01 DK DK10730679.7T patent/DK2448950T3/en active
- 2010-07-01 JP JP2012518607A patent/JP5739882B2/ja active Active
- 2010-07-01 AU AU2010266213A patent/AU2010266213B2/en active Active
- 2010-07-01 SG SG2011091733A patent/SG176799A1/en unknown
- 2010-07-01 SI SI201031148A patent/SI2448950T1/sl unknown
- 2010-07-01 RS RS20160220A patent/RS54679B1/sr unknown
- 2010-07-01 EA EA201270114A patent/EA021657B1/ru unknown
- 2010-07-01 ES ES10730679.7T patent/ES2565985T3/es active Active
- 2010-07-01 ME MEP-2016-57A patent/ME02388B/me unknown
- 2010-07-01 CA CA2766801A patent/CA2766801C/en active Active
-
2012
- 2012-09-24 US US13/625,552 patent/US8481724B2/en active Active
-
2013
- 2013-06-07 US US13/912,856 patent/US8691798B2/en active Active
-
2016
- 2016-03-24 SM SM201600084T patent/SMT201600084B/xx unknown
- 2016-04-12 CY CY20161100304T patent/CY1117489T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102482305B (zh) | 2016-07-13 |
| CA2766801C (en) | 2018-03-13 |
| US20110003986A1 (en) | 2011-01-06 |
| CN102482305A (zh) | 2012-05-30 |
| BRPI1011888A2 (pt) | 2016-04-12 |
| US20130274499A1 (en) | 2013-10-17 |
| HRP20160319T1 (hr) | 2016-04-22 |
| AU2010266213A1 (en) | 2012-02-02 |
| SI2448950T1 (sl) | 2016-05-31 |
| JP5739882B2 (ja) | 2015-06-24 |
| HUE027212T2 (en) | 2016-10-28 |
| RS54679B1 (sr) | 2016-08-31 |
| WO2011002999A1 (en) | 2011-01-06 |
| EP2448950A1 (en) | 2012-05-09 |
| AU2010266213B2 (en) | 2015-06-18 |
| CY1117489T1 (el) | 2017-04-26 |
| EP2448950B1 (en) | 2016-01-13 |
| DK2448950T3 (en) | 2016-04-04 |
| US8691798B2 (en) | 2014-04-08 |
| SMT201600084B (it) | 2016-04-29 |
| EA021657B1 (ru) | 2015-08-31 |
| US8481724B2 (en) | 2013-07-09 |
| CA2766801A1 (en) | 2011-01-06 |
| US8299242B2 (en) | 2012-10-30 |
| EA201270114A1 (ru) | 2012-05-30 |
| ME02388B (me) | 2016-09-20 |
| PL2448950T3 (pl) | 2016-06-30 |
| US20130018185A1 (en) | 2013-01-17 |
| UA108077C2 (xx) | 2015-03-25 |
| HK1169996A1 (zh) | 2013-02-15 |
| ES2565985T3 (es) | 2016-04-08 |
| JP2012532143A (ja) | 2012-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2766801C (en) | Synthesis of n4-(2, 2-dimethyl-4-[(dihydrogen phosphonoxy) methyl]-3-oxo-5-pyrido [1,4] oxazin-6-yl)-5-fluoro-n2-(3,4,5,-trimethoxyphenyl)-2,4-pyrimidinediamine disodium salt | |
| US8791259B2 (en) | Process for the preparation of Tenofovir | |
| JP5142716B2 (ja) | サイクリックエステルのルイス酸介在合成法 | |
| CA2485597C (en) | Process for preparation of cyclic prodrugs of pmea and pmpa | |
| KR20010085855A (ko) | 항바이러스성 퓨린 유도체들 | |
| WO2014150261A1 (en) | Compounds and uses thereof for the modulaton of hemoglobin | |
| CN102405220A (zh) | 噻唑衍生物及其作为p2y12受体拮抗剂的用途 | |
| AU713374B2 (en) | Nucleotide analogs | |
| JP2016094388A (ja) | ホスホン酸エステル誘導体およびその合成方法 | |
| WO2017102654A1 (en) | Phospholipidation of imidazoquinolines and oxoadenines | |
| EP3348561A1 (en) | Method for producing alkenyl phosphorus compound | |
| SK286894B6 (sk) | Spôsob výroby imidazotriazinónov substituovaných sulfónamidom | |
| CN102108086B (zh) | 一种制备对甲苯磺酰氧基甲基磷酸二乙酯的方法 | |
| JP2017522301A (ja) | テノホビルプロドラッグの新規な多結晶形並びにその製造方法及び用途 | |
| HK1169996B (en) | Synthesis of n4- (2, 2-dimethyl-4- [(dihydrogen phosphonoxy)methyl]-3-oxo-5-pyrido [1, 4]oxazin-6-yl)-5-fluoro-n2- (3, 4, 5,-trimethoxyphenyl)-2, 4- pyrimidinediamine disodium salt | |
| CA3209796A1 (en) | Methods for preparing bisphosphocins | |
| WO2011158259A1 (en) | Novel process for the preparation of (3s)-tetrahydrofuran-3-yl (is, 2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate and its pharmaceutically acceptable salts thereof | |
| CZ20011145A3 (cs) | Antivirové purinové deriváty a jejich použití |